Font

Aa Aa Aa

Background color

A A

Site version

Color Black and white
Drugs

Etamsylatе-Darnitsa

Antihaemorrhagic agents. Other systemic haemostatic drugs

Etamsylatе-Darnitsa is a medicine for preventing and stopping bleeding. It affects the first stage of haemostasis (interaction between endothelium and platelets).

Prevention and control of haemorrhages of different aetiology in superficial and internal capillaries, especially if the bleeding is caused by endothelial lesions, in particular:

– prevention and treatment of bleeding during and after surgery in otolaryngology, gynaecology, obstetrics, urology, dentistry, ophthalmology, and plastic surgery;

– prevention and treatment of capillary bleeding of different aetiology and localisation: haematuria, metrorrhagia, primary hypermenorrhea, hypermenorrhea in women with intrauterine contraceptives, nasal bleeding, bleeding from the gums;

– neonatology: prevention of periventricular haemorrhage in preterm infants.

The medicine should be administered intravenously (slowly) or intramuscularly.

The daily dose of the medicine for adults is 10–20 mg/kg body weight administered in 3–4 injections (in most cases the contents of 1–2 ampoules are administered 3–4 times per day). The daily dose for children is 5–10 mg/kg body weight.

Specialized edition for medical institutions and doctors.